drugset / Trial / NCT06342804

Food Effect on the Bioavailability of 4-MUST, Tablets, 128 mg

NCT06342804 ↗

Phase 1 Unknown 24 enrolled Valenta Pharm JSC
RandomizedCrossoverOpen-labelOther

Summary

Primary objective of the study: evaluation of the effect of food intake on the bioavailability of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) after a single oral administration on an empty stomach and after a meal, at a dose of 256 mg (two tablets). Additional aim of the study: evaluation of pharmacokinetic parameters, safety and tolerability of 4-MUST, tablets, 128 mg (Valenta Pharm JSC) in healthy volunteers after a single oral administration on an empty stomach and after a meal, at a dose of 256 mg (two tablets).

Timeline

Start
2024-03-19
Primary completion
2024-12-31
Completion
2024-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject 4-MUST Unknown 256 mg Oral

Indications